![Marcio Souza](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcio Souza
Vorstandsvorsitzender bei
PRAXIS PRECISION MEDICINES, INC.
Vermögen: 28 Mio $ am 31.05.2026
Profil
Marcio Souza is President, Chief Executive Officer & Director at Praxis Precision Medicines, Inc. since 2020.
Mr. Souza is Director at Remagine Labs, Inc. Former roles include Executive Director-Marketing at NPS Pharmaceuticals, Inc. from 2012 to 2014, Independent Director at Spyre Therapeutics, Inc. from 2021 to 2023, Independent Director at ClearPoint Neuro, Inc. in 2020, Director at ClearPoint Neuro, Inc., and Chief Operating Officer at PTC Therapeutics, Inc. from 2017 to 2020.
Education includes an MBA from Fundação Dom Cabral and undergraduate studies at the University of Sao Paulo.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 79’616 ( 0.29% ) | 28 Mio $ | 31.05.2026 |
Aktive Positionen von Marcio Souza
| Unternehmen | Position | Beginn |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Vorstandsvorsitzender | 01.04.2020 |
Ehemalige bekannte Positionen von Marcio Souza
| Unternehmen | Position | Ende |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 22.06.2023 |
| CLEARPOINT NEURO, INC. | Direktor/Vorstandsmitglied | 27.04.2020 |
| PTC THERAPEUTICS, INC. | Geschäftsführer | 01.04.2020 |
| NPS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2014 |
| CLEARPOINT NEURO, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Marcio Souza
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Fundação Dom Cabral
 Fundação Dom Cabral Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Sao Paulo
 University of Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clearpoint Neuro, Inc.
 Clearpoint Neuro, Inc. Medical SpecialtiesHealth Technology Develops and markets bio technology and surgical products | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
